相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New chemotherapy regimens and biomarkers for Chagas disease: the rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia
Cristina Alonso-Vega et al.
BMJ OPEN (2021)
New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial
Faustino Torrico et al.
LANCET INFECTIOUS DISEASES (2021)
Reversed Immunoglycomics Identifies α-Galactosyl-Bearing Glycotopes Specific for Leishmania major Infection
Alba L. Montoya et al.
JACS AU (2021)
The Glycan Structure of T. cruzi mucins Depends on the Host. Insights on the Chameleonic Galactose
Maria Eugenia Giorgi et al.
MOLECULES (2020)
Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America
Julio Alonso-Padilla et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2019)
Synthesis and characterization of α-D-Galp-(1 → 3)-β-D-Galp epitope-containing neoglycoconjugates for chagas disease serodiagnosis
Rosana Lopez et al.
CARBOHYDRATE RESEARCH (2019)
Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity
Bianca Zingales
ACTA TROPICA (2018)
Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial
Faustino Torrico et al.
LANCET INFECTIOUS DISEASES (2018)
Molecular diagnostics for Chagas disease: up to date and novel methodologies
Julio Alonso-Padilla et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2017)
Galactofuranose antigens, a target for diagnosis of fungal infections in humans
Carla Marino et al.
FUTURE SCIENCE OA (2017)
Synthesis of Galα(1,3)Galβ(1,4)GlcNAcα-, Galβ(1,4)GlcNAcα- and GlcNAc-containing neoglycoproteins and their immunological evaluation in the context of Chagas disease
Nathaniel S. Schocker et al.
GLYCOBIOLOGY (2016)
Prevalence of Trypanosoma cruzi's Discrete Typing Units in a cohort of Latin American migrants in Spain
Angela Martinez-Perez et al.
ACTA TROPICA (2016)
Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives
Maria-Jesus Pinazo et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2015)
Chagas' Disease
Caryn Bern
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Recent Clinical Trials for the Etiological Treatment of Chronic Chagas Disease: Advances, Challenges and Perspectives
Julio A. Urbina
JOURNAL OF EUKARYOTIC MICROBIOLOGY (2015)
Addition of α-O-GlcNAc to threonine residues define the post-translational modification of mucin-like molecules in Trypanosoma cruzi
Lucia Mendonca-Previato et al.
GLYCOCONJUGATE JOURNAL (2013)
Potential use of synthetic α-galactosyl-containing glycotopes of the parasite Trypanosoma cruzi as diagnostic antigens for Chagas disease
Roger A. Ashmus et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2013)
The revised Trypanosoma cruzi subspecific nomenclature: Rationale, epidemiological relevance and research applications
Bianca Zingales et al.
INFECTION GENETICS AND EVOLUTION (2012)
Synthesis of galactofuranose-containing acceptor substrates for mycobacterial galactofuranosyltransferases
Gladys C. Completo et al.
JOURNAL OF ORGANIC CHEMISTRY (2008)
Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp.
Zuleima C. Caballero et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Synthesis of the Trypanosoma cruzi LPPG heptasaccharyl myo-inositol
M Hederos et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Protozoan parasite-specific carbohydrate structures
L Mendonça-Previato et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2005)
Synthesis of α-D-Ga1p-(1→3)-β-D-Ga1f-(1→3)-D-Man, a terminal trisaccharide of Leishmania type-2 glycoinositolphospholipids
L Gandolfi-Donadio et al.
JOURNAL OF ORGANIC CHEMISTRY (2002)
Glycoinositolphospholipids, free and as anchors of proteins, in Trypanosoma cruzi
RM de Lederkremer et al.
CURRENT PHARMACEUTICAL DESIGN (2001)
Synthesis of the Leishmania LPG core heptasaccharyl myo-inositol
K Ruda et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2000)
Synthesis of galactofuranosyl-containing oligosaccharides corresponding to the glycosylinositolphospholipid of Trypanosoma cruzi
KD Randell et al.
CARBOHYDRATE RESEARCH (2000)
Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents
IC Almeida et al.
EMBO JOURNAL (2000)
The targets of the lytic antibody response against Trypanosoma cruzi
GM Krautz et al.
PARASITOLOGY TODAY (2000)
分享论文
